ResearcherRegional Centre for BiotechnologyActive in the last 2 years
Rajender K. Motiani
Matched on ORCID iD 0000-0002-8971-9008; OpenAlex author ID A5091353622. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 3
2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 2 papers
Papers 3
- The Ca2+ channel Orai3 drives gemcitabine resistance in pancreatic cancer through NFATc1-dependent SLIT3 expression. Last author DOI 10.1016/j.jbc.2026.113480↗
- SNHG10 promotes tumorigenesis through the EGFR/AKT/ERK/mTOR and miR-150-5p/VEGF-A axis, along with gemcitabine resistance in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41420-026-03040-y↗
- Orai3 Regulates Pancreatic Cancer Metastasis by Encoding a Functional Store Operated Calcium Entry Channel. Last author DOI 10.3390/cancers13235937↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Samriddhi Arora · 2 shared papers, 2021–2026 · strength 0.60
- Gouri Pandya · 1 shared paper, 2026 · strength 0.26
- Manoj Garg · 1 shared paper, 2026 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.